CTIS2023-508441-41-00进行中（未招募）1 期
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized (SHORTEN-2) clinical trial with a DOOR/RADAR analysis. - SHORTEN-II
Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla0 个研究点目标入组 306 人开始时间: 2024年6月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 306
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Adult patients (18 years or older)., Present bacteremia due to P. aeruginosa., Having received 6 days (+/-1) of active antibiotic treatment against bacteremia counted from the date of extraction of the first positive blood culture and until the moment of randomization., Have signed the informed consent for the trial.
排除标准
- •Minors under 18 years of age., Polymicrobial bacteremia including microorganisms other than P. aeruginosa. Polymicrobial bacteremia is considered the isolation in blood of more than one bacteria other than P.aeruginosa with clinical significance. P.aeruginosa bacteremias that are accompanied by isolates considered as contaminations (coagulase-negative staphylococci or viridans group streptococci, etc.) without clinical significance can be recruited for the trial, since these will not require specific treatment, and should not be considered polymicrobial bacteremia for the purposes of the assay., Patients in palliative care or with an expected survival of less than 48 hours at the time of randomization., Bacteremia due to P. aeruginosa in the previous 30 days as long as the previous infection has not been resolved., The doctor responsible for the patient does not want to include the patient in the clinical trial., Pregnant or breastfeeding women. Potentially fertile patients must have a negative pregnancy test., Focus of bacteremia not adequately controlled at least 72 hours before randomization., Bacteremia secondary to an infection that necessarily requires prolonged antibiotic treatment, greater than 7 days, including: -Post-obstructive or necrotizing pneumonia. -Lung abscesses. -Acute prostatitis. -Bone and joint infections. -Central nervous system infections. -Endovascular infections related to vascular prostheses. -Any other at the discretion of the doctor responsible for the patient., Coexistence of a different infection at the time of diagnosis of bacteremia that also requires antibiotic treatment if their treatment will be extended beyond 7 days from the diagnosis of bacteremia by P. aeruginosa. On the contrary, in the event that an infection coexists whose treatment ends before randomization, the patient may be included. Also in case there are isolates other than P. aeruginosa in samples corresponding to colonizations that do not require antibiotic treatment (asymptomatic bacteriuria, contamination of blood cultures by colonizers usual, bronchoaspirates without symptoms or signs suggestive of infection respiratory), the patient may be included in the trial.., Bacteremic pneumonia in severely immunocompromised patients, defined as: -Patients with severe neutropenia (<500 cells/mm3). -Recipients of allogeneic hematopoietic stem cell or solid organ transplant, during the first year after the transplant. -Active graft-versus-host disease requiring immunosuppressive treatment. -Patients with solid tumors who are receiving chemotherapy. -Untreated HIV infection with CD4 < 200 cells/mm3. -Patients with primary combined immunodeficiency. -Steroid treatment with prednisone > 20 mg/day (or equivalent) for 14 days prior to randomization., Bacteremia of any origin in patients with severe neutropenia (<500 cells/mm3) at the time of randomization., Bacteremia of any origin in large burns., Bacteremia produced by strains resistant to all beta-lactams and quinolones.
研究者
相似试验
进行中（未招募）
1 期
A study comparing a 7-day versus a 14-day course of antibiotics against an infection affecting the blood caused by a bacteria called Pseudomonas aeruginosa.Adult patients with bloodstream infections produced by Pseudomonas aeruginosa.MedDRA version: 20.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 22.1Level: HLTClassification code 10037132Term: Pseudomonal infectionsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-003847-10-ESFundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)304
已完成
3 期
Comparison of 7 days versus 14 days antibiotics for patients hospitalized with non-severe kidney infectioCTRI/2016/04/006810Department of Medicine Jawaharlal Institute of Postgraduate Medical Education and Research54
招募中
1 期
Comparison of the effect of seven vs fourteen days of antibiotic treatment in patients with uncomplictaed Staphylococcus aureus bloodstream infections.Staphylococcus aureus bacteremiaMedDRA version: 21.1Level: LLTClassification code 10058887Term: Staphylococcus aureus bacteremiaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-003529-13-DKThomas Benfield284
招募中
不适用
Antibiotic prophylaxis in prevention of surgical site infectio-Surgical Site Infection.IRCT201707188968N2Vice-chancellor Of Research Babol University Of Medical Sciences370
已完成
4 期
7-DAY VERSUS 10-DAY INTRAVENOUS ANTIBIOTICSFORNEONATAL SEPSIS:A RANDOMIZED CONTROLLED TRIACTRI/2013/01/003302niversity College of Medical Sciences and Guru Teg Bahadur Hospital132